JP2009540012A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540012A5
JP2009540012A5 JP2009515619A JP2009515619A JP2009540012A5 JP 2009540012 A5 JP2009540012 A5 JP 2009540012A5 JP 2009515619 A JP2009515619 A JP 2009515619A JP 2009515619 A JP2009515619 A JP 2009515619A JP 2009540012 A5 JP2009540012 A5 JP 2009540012A5
Authority
JP
Japan
Prior art keywords
diamine
pyrimidine
dimethylamino
propyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009515619A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540012A (ja
JP5306190B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/071073 external-priority patent/WO2007146977A1/en
Publication of JP2009540012A publication Critical patent/JP2009540012A/ja
Publication of JP2009540012A5 publication Critical patent/JP2009540012A5/ja
Application granted granted Critical
Publication of JP5306190B2 publication Critical patent/JP5306190B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009515619A 2006-06-15 2007-06-13 2−アニリノ−4−アミノアルキレンアミノピリミジン Expired - Fee Related JP5306190B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81387506P 2006-06-15 2006-06-15
US60/813,875 2006-06-15
PCT/US2007/071073 WO2007146977A1 (en) 2006-06-15 2007-06-13 2-anilino-4-aminoalkyleneaminopyrimidines

Publications (3)

Publication Number Publication Date
JP2009540012A JP2009540012A (ja) 2009-11-19
JP2009540012A5 true JP2009540012A5 (enExample) 2010-07-29
JP5306190B2 JP5306190B2 (ja) 2013-10-02

Family

ID=38611102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009515619A Expired - Fee Related JP5306190B2 (ja) 2006-06-15 2007-06-13 2−アニリノ−4−アミノアルキレンアミノピリミジン

Country Status (15)

Country Link
US (2) US20070293525A1 (enExample)
EP (1) EP2032543A1 (enExample)
JP (1) JP5306190B2 (enExample)
KR (1) KR20090023698A (enExample)
CN (1) CN101506176A (enExample)
AR (1) AR062822A1 (enExample)
AU (1) AU2007257701A1 (enExample)
CA (1) CA2655315A1 (enExample)
CL (1) CL2007001748A1 (enExample)
IL (1) IL195865A0 (enExample)
MX (1) MX2008016007A (enExample)
RU (1) RU2008152193A (enExample)
TW (1) TW200815368A (enExample)
WO (1) WO2007146977A1 (enExample)
ZA (1) ZA200809945B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007257650A1 (en) * 2006-06-15 2007-12-21 Boehringer Ingelheim International Gmbh 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha
LT2252300T (lt) * 2008-02-22 2017-02-10 Rigel Pharmaceuticals, Inc. 2,4-pirimidindiaminų panaudojimas aterosklerozės gydymui
CN102869775A (zh) 2009-09-30 2013-01-09 哈佛大学校长及研究员协会 通过调节自噬抑制基因产物调节自噬的方法
WO2011075560A1 (en) * 2009-12-17 2011-06-23 Merck Sharp & Dohme Corp. Aminopyrimidines as syk inhibitors
HUE029196T2 (en) 2010-06-04 2017-02-28 Hoffmann La Roche Aminoprimidine derivatives as LRRK2 modulators
SG189043A1 (en) 2010-11-10 2013-05-31 Hoffmann La Roche Pyrazole aminopyrimidine derivatives as lrrk2 modulators
KR101664106B1 (ko) * 2014-09-11 2016-10-10 한국화학연구원 폴리믹신 b 화합물을 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물
US10752699B2 (en) 2015-06-29 2020-08-25 Regents Of The University Of Minnesota Anti-APOBEC3 antibodies and methods of making and using
KR101876514B1 (ko) * 2016-11-08 2018-07-10 한국화학연구원 신규한 피리미딘화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암 및 염증질환의 예방 또는 치료용 약학적 조성물
CN109516959A (zh) * 2018-12-03 2019-03-26 陕西师范大学 2-芳氨基-4-取代嘧啶类衍生物及其在制备抗肿瘤药物中的应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB592928A (en) 1943-06-11 1947-10-03 Francis Henry Swinden Curd New pyrimidine compounds
US2443305A (en) * 1948-06-15 Pyrimidine derivatives
US2437683A (en) * 1948-03-16 Pyrimedine compounds and method of
DE833651C (de) 1943-11-02 1952-03-10 Ici Ltd Verfahren zur Herstellung von neuen Pyrimidinabkoemmlingen
GB587550A (en) 1944-09-25 1947-04-29 Francis Henry Swinden Curd New pyrimidine compounds
US3445467A (en) * 1964-05-25 1969-05-20 Ciba Geigy Corp Biphenyl diphenylalkane and diphenylether compounds,amino - substituted on the phenyl rings
FR2244520B1 (enExample) 1973-07-06 1977-02-04 Ugine Kuhlmann
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
EP0945442A1 (en) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted pyrimidine derivatives
NZ506679A (en) 1998-03-27 2002-11-26 Janssen Pharmaceutica Nv HIV inhibiting pyrimidine derivatives
DE69933680T2 (de) * 1998-08-29 2007-08-23 Astrazeneca Ab Pyrimidine verbindungen
KR20010108394A (ko) 1999-03-26 2001-12-07 다비드 에 질레스 신규 화합물
GB0016877D0 (en) 2000-07-11 2000-08-30 Astrazeneca Ab Chemical compounds
MEP13408A (en) * 2001-05-29 2010-06-10 Bayer Schering Pharma Ag Cdk inhibiting pyrimidines, production thereof and their use as medicaments
US7115617B2 (en) 2001-08-22 2006-10-03 Amgen Inc. Amino-substituted pyrimidinyl derivatives and methods of use
US6939874B2 (en) 2001-08-22 2005-09-06 Amgen Inc. Substituted pyrimidinyl derivatives and methods of use
WO2003026665A1 (en) 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
EP1453516A2 (de) 2001-10-17 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG 5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
EP1438053B1 (de) 2001-10-17 2008-09-10 Boehringer Ingelheim Pharma GmbH & Co.KG Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
BR0213792A (pt) 2001-11-01 2004-12-07 Janssen Pharmaceutica Nv Heteroaril aminas como inibidores de glicogênio sintase cinase 3beta (inibidores de gsk3)
SE0104140D0 (sv) * 2001-12-07 2001-12-07 Astrazeneca Ab Novel Compounds
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
EA200500721A1 (ru) * 2002-11-28 2005-12-29 Шеринг Акциенгезельшафт Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств
EP1571146A4 (en) * 2002-12-10 2010-09-01 Ono Pharmaceutical Co NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
WO2005003103A2 (en) 2003-06-30 2005-01-13 Astrazeneca Ab 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
JP4886511B2 (ja) 2003-07-30 2012-02-29 ライジェル ファーマシューティカルズ, インコーポレイテッド 2,4−ピリミジンジアミン化合物による自己免疫疾患の治療または予防方法
JP4741491B2 (ja) 2003-08-07 2011-08-03 ライジェル ファーマシューティカルズ, インコーポレイテッド 抗増殖剤としての2,4−ピリミジンジアミン化合物および使用
AU2005205167A1 (en) 2004-01-16 2005-07-28 Novartis Ag 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis
AU2005322855B2 (en) 2004-12-30 2012-09-20 Exelixis, Inc. Pyrimidine derivatives as kinase modulators and method of use
DE102005016634A1 (de) 2005-04-12 2006-10-19 Merck Patent Gmbh Neuartige Aza-Hetercyclen als Kinase-Inhibitoren
AU2007257650A1 (en) * 2006-06-15 2007-12-21 Boehringer Ingelheim International Gmbh 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha

Similar Documents

Publication Publication Date Title
JP2009540012A5 (enExample)
RU2008152193A (ru) 2-амино-4-аминоалкиленаминопиримидины
ES2201300T3 (es) Compuestos activos frente a receptores de iones inorganicos.
CN106977429B (zh) 用于合成和使用造影剂的组合物、方法和系统
RU2010141823A (ru) Соединения и способ снижения мочевой кислоты
BG60761B2 (bg) Арилоксифенилпропиламини
KR20050117533A (ko) 디페닐에틸렌 화합물 및 그의 용도
JP2005524631A5 (enExample)
RU2004123215A (ru) Производные пиридо(2,1-а) изохинолина в качестве ингибиторов dpp-iv
RU2009103899A (ru) Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ
RU2006116628A (ru) Новые производные имидазола и их применение в качестве фармацевтических агентов
JP2006521335A5 (enExample)
RU95122587A (ru) 1-фенилалканоны новые лиганды рецепторов 5-ht*004
JP2021521185A (ja) 神経内分泌腫瘍の治療における二重標的化のための合成物および方法
JP2017512211A (ja) アミノカルボニルカルバメート化合物
Sugie et al. Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo
RU2012120749A (ru) Производное 5-гидроксипиримидин-4-карбоксамида
Li et al. Discovery of 6-aryl-2-(3, 4, 5-trimethoxyphenyl) thiazole [3, 2-b][1, 2, 4] triazoles as potent tubulin polymerization inhibitors
RU2009122665A (ru) 4-имидазолины в качестве лигандов taar
TWI850047B (zh) 哌類化合物在製備用於聯合放療治療腫瘤的藥物中的用途
RU2004126637A (ru) Производные порфиринплатины, терапевтические активное соединение для получения средства для лечения опухолей, лекарственное средство и способ получения указанного средства
JP2010504321A5 (enExample)
TWI306401B (en) Benzothiazolium compounds
JPH09165336A5 (enExample)
RU2221794C2 (ru) Арилпиперазиновые производные, способы их получения, фармацевтическая композиция на их основе и способы лечения